Loading…
Microbot Medical Inc. is projected to rise to $2.43 by 2027, a +29% move from its current price of $1.89. MBOT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.84 | $1.89 | $1.94 | +0.06% |
| Jul 14 | $1.83 | $1.89 | $1.96 | +0.12% |
| Jul 15 | $1.81 | $1.89 | $1.98 | +0.19% |
| Jul 16 | $1.80 | $1.89 | $1.99 | +0.25% |
| Jul 17 | $1.79 | $1.90 | $2.01 | +0.31% |
| Jul 18 | $1.78 | $1.90 | $2.02 | +0.37% |
| Jul 19 | $1.78 | $1.90 | $2.03 | +0.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.78 | $1.90 | $2.03 | +0.44% |
| Week 2 | $1.74 | $1.91 | $2.09 | +0.88% |
| Week 3 | $1.71 | $1.91 | $2.15 | +1.32% |
| Week 4 | $1.68 | $1.92 | $2.20 | +1.76% |
| Week 5 | $1.66 | $1.93 | $2.24 | +2.20% |
| Week 6 | $1.65 | $1.94 | $2.28 | +2.65% |
| Week 7 | $1.63 | $1.95 | $2.32 | +3.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Microbot Medical Inc. is a medical device company that engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter.
Microbot Medical was founded in 2010 and is based in Hingham, Massachusetts.
Microbot Medical Inc. (MBOT) operates in the Healthcare sector and trades at $1.91 per share with a market capitalization of $128.28M. It is ranked 4103 in market cap terms.
The forecast path shows a gradual, long-term upside: 2026 avg $1.91 with a 2026 min of $1.62 and max of $2.79 (ROI 0, sentiment NEUTRAL), rising to 2027 avg $2.60 and 2030 avg $3.27 with a 71.3 ROI, then to 2040 avg $7.81 (ROI 309.1) and 2050 avg $15.42 (ROI 707.4) with bullish sentiment.
Overall, the outlook shifts from neutral in 2026 to bullish across the later years, signaling meaningful upside potential over the long horizon while acknowledging the inherent uncertainty in small-cap medical device equities.
A major floor 13.4% below — a decisive break under it would weaken the trend.
The nearest floor, 6.3% below — buyers have tended to step in here.
The nearest ceiling, 7.4% above — a clean break opens room to run.
A major ceiling 50.8% above — clearing it would confirm fresh momentum.
Key MBOT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MBOT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.89 | Buy | $1.88 | Buy |
| MA 10 | $1.89 | Buy | $1.88 | Buy |
| MA 20 | $1.85 | Buy | $1.87 | Buy |
| MA 50 | $1.91 | Sell | $1.94 | Sell |
| MA 100 | $2.16 | Sell | $2.06 | Sell |
| MA 200 | $2.24 | Sell | $2.17 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.63 | Neutral |
| Stoch RSI (14) | 66.13 | Neutral |
| CCI (20) | 55.12 | Neutral |
| Williams %R (14) | -33.33 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 3.85 | Buy |
| Bollinger %B (20,2) | 0.68 | Neutral |
| Stochastic %K (14) | 66.67 | Neutral |
| TRIX (15) | -0.12 | Sell |
| Awesome (5,34) | 0.03 | Buy |
| Ultimate (7,14,28) | 39.24 | Neutral |
| Momentum (10) | 0.12 | Buy |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 1.87 | Buy |
| ADX (14) | 10.17 | Neutral |
| ATR (14) | 0.04 | Info |
The 30-day technical picture shows NEUTRAL sentiment with RSI(14) at 50 and moving averages near the price: SMA50 at $1.95 and SMA200 at $2.28.
Nearby support is at $1.71 and resistance at $2.03, framing a 30‑day range of $1.57 to $2.32. The 30-day window reflects modest activity with annualized volatility around 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.62 | $1.89 | $2.66 | 0% | Neutral | |
| $1.95 | $2.43 | $3.20 | +29% | Bullish | |
| $2.25 | $2.88 | $3.92 | +52% | Bullish | |
| $2.22 | $2.89 | $4.05 | +53% | Bullish | |
| $2.23 | $2.97 | $4.25 | +57% | Bullish | |
| $2.35 | $3.18 | $4.64 | +68% | Bullish | |
| $2.36 | $3.25 | $4.82 | +72% | Bullish | |
| $2.81 | $3.92 | $5.92 | +107% | Bullish | |
| $3.20 | $4.52 | $6.94 | +139% | Bullish | |
| $3.25 | $4.67 | $7.25 | +147% | Bullish | |
| $4.09 | $6.23 | $10.26 | +229% | Bullish | |
| $7.26 | $12.25 | $21.97 | +548% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.62 | $1.89 | $2.33 | +0.00% |
| August 2026 | $1.70 | $2.01 | $2.42 | +6.13% |
| September 2026 | $1.69 | $2.00 | $2.44 | -0.26% |
| October 2026 | $1.73 | $2.07 | $2.54 | +3.26% |
| November 2026 | $1.79 | $2.14 | $2.66 | +3.75% |
| December 2026 | $1.77 | $2.13 | $2.66 | -0.51% |
Click any year to see its month-by-month MBOT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MBOT could reach as high as $2.66, with a base case around $1.89 and support toward $1.62 — roughly 0% from $1.89. A consolidation phase looks the most probable path here.
Expect MBOT to range from $1.95 to $3.20 through 2027. The $2.43 average target implies a +29% move from current prices. That is up +29% on the projected 2026 average. Momentum favours further upside here.
The MBOT price prediction for 2028 points to an average of $2.88 (low $2.25, high $3.92) — a potential gain of +52% on today's $1.89. Buyers look set to stay in control over this stretch.
In 2029, MBOT is projected to trade between $2.22 and $4.05, averaging $2.89 — a potential gain of +53% from today's $1.89. That is up 0% on the projected 2028 average. Momentum favours further upside here.
Microbot Medical Inc.'s 2030 outlook centres on $2.97, within a $2.23 to $4.25 range. That is up +3% on the projected 2029 average. That marks a +57% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, MBOT could reach as high as $4.64, with a base case around $3.18 and support toward $2.35 — roughly +68% from $1.89. Momentum favours further upside here.
Expect MBOT to range from $2.36 to $4.82 through 2032. The $3.25 average target implies a +72% move from current prices. That is up +2% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The MBOT price prediction for 2033 points to an average of $3.92 (low $2.81, high $5.92) — a potential gain of +107% on today's $1.89. Momentum favours further upside here.
In 2034, MBOT is projected to trade between $3.20 and $6.94, averaging $4.52 — a potential gain of +139% from today's $1.89. That is up +16% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Microbot Medical Inc.'s 2035 outlook centres on $4.67, within a $3.25 to $7.25 range. That is up +3% on the projected 2034 average. That marks a +147% change versus current levels. Momentum favours further upside here.
By 2040, MBOT could reach as high as $10.26, with a base case around $6.23 and support toward $4.09 — roughly +229% from $1.89. Buyers look set to stay in control over this stretch.
Expect MBOT to range from $7.26 to $21.97 through 2050. The $12.25 average target implies a +548% move from current prices. That is up +97% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MBOT today (≈ 529.100529 MBOT) could be worth
$6,480.34
+$5,480.34 (+548%) by 2050 · US Dollar
Based on the average projected MBOT price of $12.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MBOTwould be worth at today's price.
$1,000 invested in MBOT on Jul 10, 2025 (≈ 378.787864 MBOT) would be worth
$715.91
-$284.09 (-28.4%) today · 0.72× · US Dollar
Based on a MBOT entry price of $2.64 vs. today's $1.89.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.91 | $989.53 | -1.0% |
| 1 month ago | $1.77 | $1,067.8 | +6.8% |
| 3 months ago | $2.59 | $729.73 | -27.0% |
| 6 months ago | $2.13 | $887.32 | -11.3% |
| 1 year ago | $2.64 | $715.91 | -28.4% |
| All time (5.0y) ago | $7.45 | $253.69 | -74.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MBOT forecast.
Our base-case forecast reaches $3.80 around 2033.
Implied market cap at $3.80: $255.23M
The multi-year forecast points to a rising price path, with 2030 averaging $3.27 and a max of $4.84 (min $2.39), yielding a 71.3 ROI and bullish sentiment. By 2040, the average price is forecast at $7.81 with a 309.1 ROI, and by 2050 the average is $15.42 with a 707.4 ROI, signaling substantial long-term upside.
From 2027 onward, forecasts are bullish, with 2027 avg $2.60 and 2028 avg $3.15 and 2029 avg $3.13, continuing to 2031–2035 where average prices rise toward $3.56, $4.67, $5.42, and $5.49 respectively as part of the upward trajectory. The company’s collaboration with Corewell Health for LIBERTY development and work with Emory University on autonomous robotics in endovascular procedures provide potential catalysts that could influence progress, though these are not guarantees. These are speculative estimates, and actual results will depend on market, regulatory, and adoption dynamics.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $3.27 with a min of $2.39 and a max of $4.84; ROI 71.3; sentiment bullish.
The forecast turns bullish from 2027 onward with an average price of $2.60 in 2027 and $3.27 in 2030, rising to an average of $15.42 by 2050 with ROI 707.4; 2026 is neutral. These are estimates, not guarantees.
Yes. For 2026 the min is $1.62, avg $1.91, max $2.79; 2027 min $2.06, avg $2.60, max $3.50.
Current price: $1.91. Market cap: $128.28M.
Sentiment NEUTRAL; RSI14 50; SMA50 $1.95; SMA200 $2.28; support $1.71; resistance $2.03; 30-day range $1.57–$2.32; annualized volatility 60%.
Microbot Medical Inc. Community Discussion
0Share your Microbot Medical Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.